Hoth Therapeutics, Inc. (HOTH) NASDAQ
0.80
+0.0482(+6.43%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 13.67M |
| Enterprise Value | 7.43M |
| P/E Ratio | -0.99 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.01 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.49 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -1.64 |
| Return On Equity | -1.4 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -11.11M |
| Net Income | -12.47M |
| Diluted EPS | -0.9 |
Balance Sheet
| Total Cash | 6.25M |
| Total Cash/Share | 0.4 |
| Total Debt | 5,678 |
| Total Debt/Equity | 0 |
| Current Ratio | 4.68 |
| Book Value Per Share | 0.4 |
Price History
| 52-Week Change | -0.24 |
| 52-Week High | 2.12 |
| 52-Week Low | 0.49 |
| Moving Average 50 Days | 0.88 |
| Moving Average 200 Days | 1.18 |
Statistics
| Average Volume | 2.65M |
| Shares Outstanding | 13.26M |
| % Held by Institutions | 7.16 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | October 26, 2022 |
